The relationship of symptom dimensions with premorbid adjustment and cognitive characteristics at first episode psychosis: Findings from the EU-GEI study
Autor:
Ferraro, Laura
; La Cascia, Caterina
; La Barbera, Daniele
; Sánchez-Gutiérrez, Teresa
; Tripoli, Giada
; Seminerio, Fabio
; Sartorio, Crocettarachele
; Sideli, Lucia
; Arango, Celso
; Arrojo, Manuel
; Bernardo, Miguel
; Bobes, Julio
; Del-Ben, Cristina Marta
; Gayer-Anderson, Charlotte
; Jongsma, Hannah E.
; Kirkbride, James B.
; Lasalvia, Antonio
; Tosato, Sarah
; Llorca, Pierre-Michel
; Menezes, Paulo Rossi
; Rutten, Bart P.
; Santos, Jose Luis
; Sanjuán, Julio
; Selten, Jean-Paul
; Szöke, Andrei
; Tarricone, Ilaria
; Muratori, Roberto
; Tortelli, Andrea
; Velthorst, Eva
; Rodriguez, Victoria
; Quattrone, Andrea
; Jones, Peter B.
; Van Os, Jim
; Vassos, Evangelos
; Morgan, Craig
; de Haan, Lieuwe
; Reininghaus, Ulrich
; Cardno, Alastair G.
; Di Forti, Marta
; Murray, Robin M.
; Quattrone, Diego
Fecha:
2021Palabra clave:
Revista / editorial:
Elsevier B.V.Tipo de Ítem:
articleResumen:
Premorbid functioning and cognitive measures may reflect gradients of developmental impairment across diagnostic categories in psychosis. In this study, we sought to examine the associations of current cognition and premorbid adjustment with symptom dimensions in a large first episode psychosis (FEP) sample. We used data from the international EU-GEI study. Bifactor modelling of the Operational Criteria in Studies of Psychotic Illness (OPCRIT) ratings provided general and specific symptom dimension scores. Premorbid Adjustment Scale estimated premorbid social (PSF) and academic adjustment (PAF), and WAIS-brief version measured IQ. A MANCOVA model examined the relationship between symptom dimensions and PSF, PAF, and IQ, having age, sex, country, self-ascribed ethnicity and frequency of cannabis use as confounders. In 785 patients, better PSF was associated with fewer negative (B = −0.12, 95% C.I. −0.18, −0.06, p < 0.001) and depressive (B = −0.09, 95% C.I. −0.15, −0.03, p = 0.032), and more manic (B = 0.07, 95% C.I. 0.01, 0.14, p = 0.023) symptoms. Patients with a lower IQ presented with slightly more negative and positive, and fewer manic, symptoms. Secondary analysis on IQ subdomains revealed associations between better perceptual reasoning and fewer negative (B = −0.09, 95% C.I. −0.17, −0.01, p = 0.023) and more manic (B = 0.10, 95% C.I. 0.02, 0.18, p = 0.014) symptoms. Fewer positive symptoms were associated with better processing speed (B = −0.12, 95% C.I. −0.02, −0.004, p = 0.003) and working memory (B = −0.10, 95% C.I. −0.18, −0.01, p = 0.024). These findings suggest that the negative and manic symptom dimensions may serve as clinical proxies of different neurodevelopmental predisposition in psychosis.
Este ítem aparece en la(s) siguiente(s) colección(es)
Estadísticas de uso
Año |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Vistas |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
52 |
75 |
127 |
Descargas |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study
Rodríguez-Toscano, Elisa; Alloza, Clara; Fraguas, David; Durán-Cutilla, Manuel; Roldán, Laura; Sánchez-Gutiérrez, Teresa; López-Montoya, Gonzalo; Parellada, Mara; Moreno, Carmen; Gayer-Anderson, Charlotte; E Jongsma, Hannah; Di Forti, Marta; Quattrone, Diego; Velthorst, Eva; de Haan, Lieuwe; Selten, Jean-Paul; Szöke, Andrei; Llorca, Pierre-Michel; Tortelli, Andrea; Bobes, Julio; Bernardo, Miguel; Sanjuán, Julio; Santos, José Luis; Arrojo, Manuel; Tarricone, Ilaria; Berardi, Domenico; Ruggeri, Mirella; Lasalvia, Antonio; Ferraro, Laura; La Cascia, Caterina; La Barbera, Daniele; Rossi Menezes, Paulo; Del-Ben, Cristina Marta; EU-GEI WP2 Group; Rutten, Bart P.; van Os, Jim; Jones, Peter B.; M. Murray, Robin; B. Kirkbride, James; Morgan, Craig; Díaz-Caneja, Covadonga M.; Arango, Celso (Schizophrenia Bulletin, 2023)Background: Use of illegal stimulants is associated with an increased risk of psychotic disorder. However, the impact of stimulant use on odds of first-episode psychosis (FEP) remains unclear. Here, we aimed to describe ... -
Tobacco use in first-episode psychosis, a multinational EU-GEI study
Sanchez-Gutierrez, Teresa; Rodriguez-Toscano, E.; Ferraro, Laura; Parellada, Mara; Calvo, Ana; Roldan, Laura; López, G.; Rapado-Castro, Marta; La Barbera, Daniele; La Cascia, Caterina; Tripoli, Giada; Di Forti, Marta; Murray, Robin M.; Quattrone, Diego; Morgan, Craig; Van Os, Jim; Garcia-Portilla, P.; Al-Halabi, S.; Bobes, Julio; de Haan, Lieuwe; Bernardo, Miguel; Santos, Jose Luis; Sanjuán, Julio; Arrojo, Manuel; Ferchiou, A.; Szöke, Andrei; Rutten, Bart P.; Stilo, S.; D'Andrea, G.; Tarricone, Ilaria; Diaz-Caneja, C. M.; Arango, Celso (Psychological Medicine, 2023)BackgroundTobacco is a highly prevalent substance of abuse in patients with psychosis. Previous studies have reported an association between tobacco use and schizophrenia. The aim of this study was to analyze the relationship ... -
Differences in lifetime patterns of psychostimulants and their impact on the proportion of patients with first-episode psychosis attributable to psychostimulants use across europe
Duran-Cutilla, Manuel; Toscano, Elisa Rodriguez; Fraguas, David; López, G.; Rapado-Castro, Marta; Roldán, Laura; Sánchez-Gutiérrez, Teresa; Calvo, Ana; Martínez-Caneja, Covadonga; Arango, Celso (Schizophrenia Bulletin, 18/05/2020)Meeting Abstract de la conferencia "Congress of the Schizophrenia-International-Research-Society (SRIS)", Italia, 2020